Australia markets open in 2 hours 11 minutes

BioNTech SE (BNTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
86.81+0.64 (+0.74%)
At close: 04:00PM EDT
86.81 0.00 (0.00%)
After hours: 05:49PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 20.92B
Enterprise value 3.54B
Trailing P/E 21.24
Forward P/E 7.04
PEG ratio (5-yr expected) N/A
Price/sales (ttm)5.17
Price/book (mrq)0.97
Enterprise value/revenue 0.93
Enterprise value/EBITDA 3.25

Trading information

Stock price history

Beta (5Y monthly) 0.23
52-week change 3-25.76%
S&P500 52-week change 320.07%
52-week high 3125.83
52-week low 385.21
50-day moving average 391.27
200-day moving average 3101.40

Share statistics

Avg vol (3-month) 3641.57k
Avg vol (10-day) 3796.05k
Shares outstanding 5240.99M
Implied shares outstanding 6240.99M
Float 888.96M
% held by insiders 162.84%
% held by institutions 118.34%
Shares short (28 Mar 2024) 43.08M
Short ratio (28 Mar 2024) 44.33
Short % of float (28 Mar 2024) 46.42%
Short % of shares outstanding (28 Mar 2024) 41.29%
Shares short (prior month 29 Feb 2024) 42.92M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 317 June 2022
Ex-dividend date 402 June 2022
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023


Profit margin 24.36%
Operating margin (ttm)40.00%

Management effectiveness

Return on assets (ttm)2.62%
Return on equity (ttm)4.62%

Income statement

Revenue (ttm)3.82B
Revenue per share (ttm)15.87
Quarterly revenue growth (yoy)-65.40%
Gross profit (ttm)N/A
Net income avi to common (ttm)930.3M
Diluted EPS (ttm)4.09
Quarterly earnings growth (yoy)-79.90%

Balance sheet

Total cash (mrq)16.55B
Total cash per share (mrq)69.61
Total debt (mrq)219.1M
Total debt/equity (mrq)1.08%
Current ratio (mrq)9.43
Book value per share (mrq)85.17

Cash flow statement

Operating cash flow (ttm)5.37B
Levered free cash flow (ttm)4.14B